Acquirer Profile
Lilly Acquisitions & Deals (2026)
biotechnology · Pharmaceuticals · Biotechnology
Deals tracked
4
Combined value
$10.4B
Primary sector
biotechnology
Active
2026
FireStrike tracks every Lilly acquisition, merger, and strategic investment in real time. This page covers 4 Lilly deals totaling $10.4B in disclosed deal value, spanning biotechnology, Pharmaceuticals, Biotechnology. Data covers 2026.
Lilly Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Centessa Pharmaceuticals Pharmaceuticals | Apr 2026 | |
Kelonia Therapeutics biotechnology | Apr 2026 | |
CrossBridge Bio Biotechnology | Apr 2026 | |
CrossBridge Bio, Inc. biotechnology | Apr 2026 |
Lilly Acquisitions — FAQ
How many acquisitions has Lilly made?
Lilly has made 4 acquisitions and deals tracked on FireStrike, totaling $10.4B in combined deal value.
What sectors does Lilly acquire in?
Lilly primarily acquires in biotechnology, Pharmaceuticals, Biotechnology.
What is Lilly's most recent acquisition?
Lilly's most recent tracked acquisition is Centessa Pharmaceuticals for $7.8B, announced Apr 2026.
Get every Lilly deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →